What is the ICD-10 code for myelodysplastic syndrome?

The ICD-10 code for myelodysplastic syndrome is D46, with specific subtypes such as D46.0 for refractory anemia without ring sideroblasts and D46.1 for refractory anemia with ring sideroblasts.

How do you code refractory anemia with ring sideroblasts?

Refractory anemia with ring sideroblasts is coded as D46.1. Ensure documentation includes bone marrow biopsy results showing ≥15% ring sideroblasts.

ICD-10 Coding for Myelodysplastic Syndrome(D46.0, D46.1, D46.22)

Save

Comprehensive guide to ICD-10 coding for myelodysplastic syndrome, including specific codes, documentation requirements, and common pitfalls.

Also known as:

MDSPreleukemia

Related ICD-10 Code Ranges

Complete code families applicable to Myelodysplastic Syndrome

C00-D49Primary Range

Neoplasms

→

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

Code	Description	When to Use	Key Documentation
D46.0	Refractory anemia without ring sideroblasts, so stated	Use when refractory anemia is diagnosed without the presence of ring sideroblasts.	Bone marrow biopsy showing dysplasia in ≥10% of cells in one or more myeloid cell lines Absence of ring sideroblasts
D46.1	Refractory anemia with ring sideroblasts	Use when refractory anemia is diagnosed with the presence of ring sideroblasts.	Bone marrow biopsy showing ≥15% ring sideroblasts SF3B1 mutation may be present
D46.9	Myelodysplastic syndrome, unspecified	Use when MDS is diagnosed but specific subtype is not documented.	General diagnosis of MDS without specific subtype identified

Primary ICD-10-CM Codes

Refractory anemia without ring sideroblasts, so stated

D46.0Billable

Differential Codes

Alternative codes to consider when ruling out similar conditions

Refractory anemia with ring sideroblastsD46.1

Refractory anemia without ring sideroblastsD46.0

Documentation & Coding Risks

Avoid these common issues when documenting Myelodysplastic Syndrome.

Failure to document specific subtype of MDS.

Impact

Clinical: May lead to inappropriate treatment plans., Regulatory: Increases risk of audit and compliance issues., Financial: Potential for reduced reimbursement.

Mitigation

Educate clinicians on the importance of detailed documentation., Implement checklists for documentation requirements.

Using D46.9 when specific subtype is documented.

Impact

Reimbursement: May result in lower reimbursement rates., Compliance: Increases risk of audit due to lack of specificity., Data Quality: Reduces accuracy of clinical data.

Mitigation

Ensure documentation specifies the subtype of MDS for accurate coding.

Use of unspecified codes

Impact

High audit risk when using D46.9 without specific subtype documentation.

Mitigation

Encourage detailed documentation and use of specific codes.

Frequently Asked Questions

Documentation requirements, coding pitfalls and FAQs for conditions coded with D46.0.

Myelodysplastic Syndromes→

Primary Code

D46.0

Refractory anemia without ring sideroblasts, so stated

Quick Navigation

ICD-10 codes4

Coding risks3

FAQs2

ICD-10 Coding for Myelodysplastic Syndrome(D46.0, D46.1, D46.22)

Documentation & Coding Risks

Frequently Asked Questions

What is the ICD-10 code for myelodysplastic syndrome?

How do you code refractory anemia with ring sideroblasts?

Related condition guides